Who owns Minerva Neurosciences Inc?
- Ticker: NERV
- CUSIP Number: 603380205
Tip: Access positions for across all investors
Analyze quarterly positions in Minerva Neurosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Minerva Neurosciences stock
Who bought or sold Minerva Neurosciences Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Federated Investors | 5.1M | $31M | -5% | Mar 2026 |
|
| Vivo Capital | 4.3M | $26M | 0% | Mar 2026 |
|
| Henderson Group | 4.3M | $26M | 100% | Mar 2026 |
|
| Balyasny Asset Management | 4.3M | $26M | 100% | Mar 2026 |
|
| Logos Global Management | 3.2M | $19M | -3% | Mar 2026 |
|
| Farallon Capital Management | 2.4M | $14M | 0% | Mar 2026 |
|
| Foresite Capital Management VI | 2.0M | $12M | 100% | Mar 2026 |
|
| Vanguard Capital Management | 1.8M | $11M | 100% | Mar 2026 |
|
| Ally Bridge Group | 1.7M | $10M | 0% | Mar 2026 |
|
| Adage Capital Partners GP | 1.4M | $8.5M | -50% | Mar 2026 |
|
| Trails Edge Capital Partners | 1.4M | $8.5M | 100% | Mar 2026 |
|
| Longwood Capital Partners | 710k | $4.3M | 0% | Mar 2026 |
|
| Millennium Management | 708k | $4.3M | 414% | Mar 2026 |
|
| BlackRock | 625k | $3.8M | 760% | Mar 2026 |
|
| Geode Capital Management | 339k | $2.0M | 384% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 264k | $1.6M | 100% | Mar 2026 |
|
| Seven Fleet Capital Management | 249k | $1.5M | 100% | Mar 2026 |
|
| Marshall Wace | 219k | $1.3M | 100% | Mar 2026 |
|
| Susquehanna International | 119k | $718k | 100% | Mar 2026 |
|
| Northern Trust | 93k | $562k | 100% | Mar 2026 |
|
| Renaissance Technologies | 90k | $540k | -40% | Mar 2026 |
|
| UBS Group | 68k | $407k | 3639% | Mar 2026 |
|
| State Street Corporation | 56k | $340k | 135% | Mar 2026 |
|
| Apella Capital | 42k | $202k | 0% | Jun 2026 |
|
| Brendel Financial Advisors | 42k | $252k | 100% | Mar 2026 |
|
| Bank of America Corporation | 40k | $241k | 100% | Mar 2026 |
|
| Goldman Sachs Group | 32k | $193k | 100% | Mar 2026 |
|
| Charles Schwab Investment Management | 31k | $187k | 100% | Mar 2026 |
|
| Brevan Howard Capital Management | 29k | $173k | 100% | Mar 2026 |
|
| Morgan Stanley | 24k | $147k | 120% | Mar 2026 |
|
| Vanguard Global Advisers | 24k | $144k | 100% | Mar 2026 |
|
| Two Sigma Investments | 21k | $129k | -4% | Mar 2026 |
|
| Cannon Global Investment Management | 18k | $107k | 100% | Mar 2026 |
|
| OMERS Administration Corporation | 10k | $62k | 100% | Mar 2026 |
|
| Acadian Asset Management | 4.8k | $28k | -55% | Mar 2026 |
|
| CWM | 420.00 | $2.5k | 0% | Mar 2026 |
|
| Larson Financial Group | 400.00 | $2.4k | 0% | Mar 2026 |
|
| SBI Securities | 251.00 | $1.5k | 0% | Mar 2026 |
|
| Barclays | 146.00 | $880.000400 | 100% | Mar 2026 |
|
| Northwestern Mutual Wealth Management Company | 100.00 | $602.000000 | 0% | Mar 2026 |
|
| Royal Bank of Canada | 92.00 | $1.0k | 100% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 62.00 | $374.002600 | 0% | Mar 2026 |
|
Who sold out of Minerva Neurosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Lion Point Capital | Dec 2025 | 35k | $141k |
| Deutsche Bank Aktiengesellschaft | Dec 2025 | 1.5k | $6.0k |
| Tower Research Capital | Dec 2025 | 501.00 | $2.0k |